Table 1 Baseline patient characteristics (n=35)
Patient characteristic | |
|---|---|
Age, median (range) | 56 (29–70) |
Gender | |
 Male (%) | 18 (51) |
 Female (%) | 17 (49) |
ECOG performance status | |
 0 (%) | 15 (43) |
 1 (%) | 15 (43) |
 2 (%) | 4 (11) |
 Missing (%) | 1 (3) |
Onset of AML | |
 De novo (%) | 23 (66) |
 Therapy-related (%) | 12 (34) |
 Prior MDS/MPN (%) | 4 (11) |
Indication for treatment | |
 Primary refractory (%) | 10 (29) |
 First relapse (%) | 21 (60) |
 Second relapse (%) | 4 (11) |
Prior unsuccessful salvage chemotherapy (%) | 7 (20) |
Prior allogeneic HCT (%) | 10 (29) |
Cytogenetics | |
 Favorable (%) | 3 (9) |
 Intermediate (%) | 19 (54) |
 Poor (%) | 13 (37) |
WBC k/cumm (range) | 2.5 (0.2–14.7) |
BM blast % (range) | 33 (0–96) |
